Roots Analysis is pleased to announce the publication of its recentstudy, titled, “Cell Therapy Manufacturing Market (3rdEdition), 2019 - 2030.”
The report features an extensive study of the currentmarket landscape and future opportunities associated with cell therapymanufacturing. It focuses on both contract manufacturers, as well as developerswith in-house manufacturing facilities, offering in-depth analyses of thevarious business entities that are engaged in this domain, across differentglobal regions. Amongst other elements, the report includes:
§ An analysis of the various expansion initiatives undertakenby service providers, in order to augment their respective cell therapy manufacturingcapabilities, over the period 2015-2019.
§ An analysis of the recent partnerships focused on themanufacturing of cell-based therapies, which have been established in theperiod 2014-2019.
§ Informed estimates of the annual commercial and clinicaldemand for cell therapies, in terms of number of cells produced and areadedicated to manufacturing.
§ An estimate of the overall, installed capacity formanufacturing cell-based therapies based on information reported by industrystakeholders in the public domain A competitiveness analysis of biologicaltargets, featuring insightful pictorial summaries and representations.
§ A detailed analysis of the various factors that are likelyto influence the pricing of cell-based therapies, featuring different models /approaches that may be adopted by manufacturers while deciding the prices oftheir proprietary offerings.
§ A qualitativeanalysis, highlighting the various factors that need to be taken intoconsideration by cell therapy developers while deciding whether to manufacturetheir respective products in-house or engage the services of a CMO.
§ An elaborate discussion on the role of automationtechnologies in improving current manufacturing methods.
§ A discussion on celltherapy manufacturing regulations across various geographies, including NorthAmerica, Europe, and Asia Pacific.
§ Elaborate profiles of key players (industry andnon-industry) that offer contract manufacturing services.
§ A discussion on affiliated trends, key drivers andchallenges, which are likely to impact the industry’s evolution, under acomprehensive SWOT framework.
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
§ Typeof therapy
§ T-celltherapies (CAR-T therapies, TCR therapies, TIL therapies)
§ Dendriticcell therapies
§ Tumorcell therapies
§ NKcell therapies
§ Stemcell therapies
§ Source of cells
§ Scaleof operation
§ Purposeof manufacturing
§ Contract manufacturing
§ In-house manufacturing
§ Keygeographical regions
§ North America
§ Asia Pacific
§ Rest of the world
Keycompanies covered in the report
§ BioNTech Innovative Manufacturing Services
§ Cell Therapies
§ Cell and Gene Therapy Catapult
§ Center for Cell and Gene Therapy, Baylor College of Medicine
§ Centre for Cell Manufacturing Ireland, National Universityof Ireland
§ Clinical Cell and Vaccine Production Facility, Universityof Pennsylvania
§ Cognate BioServices
§ Guy’s and St. Thomas’ GMP Facility, Guy’s Hospital
§ Hitachi Chemical
§ KBI Biopharma
§ Laboratory for Cell and Gene Medicine, Stanford University
§ Molecular and Cellular Therapeutics, University ofMinnesota
§ Newcastle Cellular Therapies Facility, Newcastle University
§ Nikon CeLL innovation
§ Rayne Cell Therapy Suite, King’s College London
§ Roslin Cell Therapies
§ Scottish National Blood Transfusion Services CellularTherapy Facility, Scottish Centre for Regenerative Medicine
§ Sydney Cell and Gene Therapy
§ WuXi Advanced Therapies
For additionaldetails, please visit
You may also beinterested in the following titles:
+1 (415) 800 3415